Lindsay Laign, NP
Family · Martinsburg, WVNPI 1871223024
Payments from drug & device makers
Across 265 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$704
- Novo Nordisk$604
- Lilly USA, LLC$505
- GSK$503
- Exact Sciences$456
- Amgen$433
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $704 |
| Novo Nordisk | 31 | $604 |
| Lilly USA, LLC | 32 | $505 |
| GSK | 29 | $503 |
| Exact Sciences | 20 | $456 |
| Amgen | 22 | $433 |
| Pfizer | 25 | $430 |
| Boehringer Ingelheim | 10 | $229 |
| AbbVie | 12 | $225 |
| Idorsia Pharmaceuticals US Inc | 10 | $143 |
| Merck | 6 | $136 |
| Bayer | 6 | $128 |
| Otsuka America Pharmaceutical, Inc. | 5 | $73 |
| Sanofi Pasteur Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $43 |
| Dynavax Technologies Corporation | 2 | $42 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Johnson & Johnson | 2 | $29 |
| Novartis | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Organon | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$4,969 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $79,410 |
| JardianceEmpagliflozin | 55 | $59,897 |
| EliquisApixaban | 38 | $29,765 |
| MounjaroTirzepatide | 23 | $27,818 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $25,009 |
| VraylarCariprazine Hcl | 13 | $18,501 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $18,063 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $8,890 |
| LinzessLinaclotide | 11 | $8,166 |
| Arnuity ElliptaFluticasone Furoate | 18 | $5,767 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 92 | $2,806 |
| Rosuvastatin Calcium | 224 | $2,259 |
| Atorvastatin Calcium | 196 | $1,662 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,590 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 11 | $1,348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $604 | $79,41074 claims |
| Boehringer IngelheimJardiance | $229 | $59,89755 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $503 | $30,77647 claims |
| PfizerEliquis | $430 | $29,76538 claims |
| Lilly USA, LLCMounjaro | $505 | $27,81823 claims |
| AbbVieVraylar, Linzess, Synthroid | $225 | $27,44645 claims |
| AstraZenecaBreztri Aerosphere | $704 | $18,06328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.
Other family in Martinsburg
- Stephanie GladdenMartinsburg$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.